BUZZ-Nutrien rises after Morgan Stanley upgrades US-listed shares to 'overweight'
I'm PortAI, I can summarize articles.
U.S.-listed shares of Nutrien (NTR) rose 2.1% to $62.59 after Morgan Stanley upgraded the stock to 'overweight' from 'equal-weight' and raised the price target to $77 from $70, indicating a 25.6% upside. The firm anticipates moderate potash price increases in 2026 and expects EBITDA estimates to be about 12% above consensus due to higher potash price forecasts. Currently, 14 out of 24 brokerages rate the stock as 'buy' or higher, with a median price target of $66.20.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments